© MSF / lumierenoire.ch
MSF launched the ‘Make it Happen’ campaign in 2009, calling on nine pharmaceutical companies to put their HIV medicines patents in the patent pool being set up by UNITAID.
MSF’s campaign in support of a medicines patent pool calls on drug companies to put their HIV patents in the pool for all developing countries to deliver affordable, life-saving medicines.

Gilead became the first company to license several HIV drugs to the Medicines Patent Pool which could help ensure that new treatment options are available in developing countries. But, disappointingly, it excludes key countries with large numbers of people living with HIV.
Kenya 2011 © Sven Torfinn

© MSF / lumierenoire.ch
MSF launched the ‘Make it Happen’ campaign in 2009, calling on nine pharmaceutical companies to put their HIV medicines patents in the patent pool being set up by UNITAID.

Austria 2010 © Marcell Nimfuehr / MSF
By December 2009, almost 300 000 letters were sent by supporters from 14 countries in nine languages to the nine companies being asked to put their patents in the pool.
12 July 2011
Gilead Licence Expands Access, But Several Countries Left Out
11 February 2011
Medicines Patent Pool Releases Status of Negotiations with HIV Medicines Patent Holders
30 September 2010
First patent goes into the Medicines Patent Pool - drug companies must now follow suit

© REUTERS / Finbarr O'Reilly
Patients on HIV treatment and doctors from MSF’s project in Khayelitsha, South Africa, explain why they are backing the creation of a patent pool.
Track the progress of the Medicines Patent Pool by visiting their website or following them on Twitter, @MedsPatentPool.
You can directly access the status of negotiations with companies here